Quick Takeaways
- Bain Capital Life Sciences Opportunities IV, L.P. filed SCHEDULE 13G/A for OLEMA PHARMACEUTICALS, INC. Common Stock, par value $0.0001 per share (OLMA).
- Disclosed ownership: 10%.
- Date of event: 08 Jan 2025.
Bain Capital Life Sciences Opportunities IV, L.P. - 08 Jan 2025 SCHEDULE 13G/A Report for OLEMA PHARMACEUTICALS, INC. Common Stock, par value $0.0001 per share (OLMA)
- Filing Manager
- Bain Capital Life Sciences Opportunities IV, L.P.
- Reporting Manager
- Bain Capital Life Sciences Opportunities IV, L.P.
- Symbol
- OLMA
- Shares outstanding
- 71,028,829 shares
- Disclosed Ownership
- 7,095,780 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Jan 2025, 16:24:53 UTC
- Date of event
- 08 Jan 2025
- Next filing
- 15 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Bain Capital Life Sciences Opportunities IV, L.P. disclosed 10% ownership in OLEMA PHARMACEUTICALS, INC. Common Stock, par value $0.0001 per share (OLMA) on 08 Jan 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Jan 2025, 16:24.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Bain Capital Life Sciences Opportunities IV, L.P. | 10% | 7,095,780 | 0 | 7,095,780 | /s/ Andrew Hack | Partner |